| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |